Stock Track | Precigen Soars 5.96% as H.C. Wainwright Raises Price Target to $9

Stock Track11-14

Precigen (PGEN) stock is soaring 5.96% in pre-market trading on Friday, following a bullish move by H.C. Wainwright. The investment firm has raised its price target on Precigen to $9 from $8.50, while maintaining a Buy rating on the shares.

The price target increase comes on the heels of Precigen's Q3 report. H.C. Wainwright's decision to boost its outlook for the stock suggests confidence in the company's recent performance and future prospects. This positive analyst action has sparked renewed interest in Precigen among investors, driving the stock's significant pre-market rally.

While specific details from the Q3 report that led to the upgraded price target were not provided, the maintained Buy rating indicates that H.C. Wainwright continues to see potential upside for Precigen. Investors will likely be watching closely for any further analyst commentary or company updates that could provide additional insights into Precigen's financial health and growth trajectory.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1170155763?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-14 22:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170155763","market":"hk","top_or_hot":-1,"title":"Stock Track | Precigen Soars 5.96% as H.C. Wainwright Raises Price Target to $9","media":"Stock Track","content":"<p>Precigen (PGEN) stock is soaring 5.96% in pre-market trading on Friday, following a bullish move by H.C. Wainwright. The investment firm has raised its price target on Precigen to $9 from $8.50, while maintaining a Buy rating on the shares.</p>\n\n<p>The price target increase comes on the heels of Precigen's Q3 report. H.C. Wainwright's decision to boost its outlook for the stock suggests confidence in the company's recent performance and future prospects. This positive analyst action has sparked renewed interest in Precigen among investors, driving the stock's significant pre-market rally.</p>\n\n<p>While specific details from the Q3 report that led to the upgraded price target were not provided, the maintained Buy rating indicates that H.C. Wainwright continues to see potential upside for Precigen. Investors will likely be watching closely for any further analyst commentary or company updates that could provide additional insights into Precigen's financial health and growth trajectory.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Precigen Soars 5.96% as H.C. Wainwright Raises Price Target to $9</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Precigen Soars 5.96% as H.C. Wainwright Raises Price Target to $9\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-14 22:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Precigen (PGEN) stock is soaring 5.96% in pre-market trading on Friday, following a bullish move by H.C. Wainwright. The investment firm has raised its price target on Precigen to $9 from $8.50, while maintaining a Buy rating on the shares.</p>\n\n<p>The price target increase comes on the heels of Precigen's Q3 report. H.C. Wainwright's decision to boost its outlook for the stock suggests confidence in the company's recent performance and future prospects. This positive analyst action has sparked renewed interest in Precigen among investors, driving the stock's significant pre-market rally.</p>\n\n<p>While specific details from the Q3 report that led to the upgraded price target were not provided, the maintained Buy rating indicates that H.C. Wainwright continues to see potential upside for Precigen. Investors will likely be watching closely for any further analyst commentary or company updates that could provide additional insights into Precigen's financial health and growth trajectory.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PGEN","symbol_name":"Precigen","start_time":0,"source_url":"","article_id":"1170155763","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170155763","pubTimestamp":1763130773,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Precigen (PGEN) stock is soaring 5.96% in pre-market trading on Friday, following a bullish move by H.C. Wainwright. The investment firm has raised its price target on Precigen to $9 from $8.50,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PGEN":"Precigen"},"translate_title":"股票追踪|Precigen飙升5.96%，成为H.C.Wainwright将目标价上调至9美元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PGEN":1},"content_text":"Precigen (PGEN) stock is soaring 5.96% in pre-market trading on Friday, following a bullish move by H.C. Wainwright. The investment firm has raised its price target on Precigen to $9 from $8.50, while maintaining a Buy rating on the shares.\nThe price target increase comes on the heels of Precigen's Q3 report. H.C. Wainwright's decision to boost its outlook for the stock suggests confidence in the company's recent performance and future prospects. This positive analyst action has sparked renewed interest in Precigen among investors, driving the stock's significant pre-market rally.\nWhile specific details from the Q3 report that led to the upgraded price target were not provided, the maintained Buy rating indicates that H.C. Wainwright continues to see potential upside for Precigen. Investors will likely be watching closely for any further analyst commentary or company updates that could provide additional insights into Precigen's financial health and growth trajectory.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1170155763","isCrawlerRequest":true}